Over recent decades, advancements in diabetes management, including improved insulin therapies, continuous glucose monitoring, and multidisciplinary care approaches, have contributed to extended life expectancy in individuals with T1D (11) and type 2 diabetes (T2D) (12). The gene discussed is INS; the disease is diabetes mellitus.